Artykuły w czasopismach na temat „XP”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „XP”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Cowham, R. "To XP or not to XP?" ITNOW 47, no. 2 (2005): 16. http://dx.doi.org/10.1093/itnow/bwi030.
Pełny tekst źródłaFischer, R., M. Uhl, and H. Vonach. "Nb93(n,xp),Agnat(n,xp), andInnat(n,xp) reactions at 14.1 MeV." Physical Review C 37, no. 2 (1988): 578–86. http://dx.doi.org/10.1103/physrevc.37.578.
Pełny tekst źródłaSonia, Archana Singhal, and Hema Banati. "FISA-XP." ACM SIGSOFT Software Engineering Notes 39, no. 3 (2014): 1–14. http://dx.doi.org/10.1145/2597716.2597728.
Pełny tekst źródłaLitts, Thom, and Jeff Kopaska. "RIP XP." Fisheries 39, no. 4 (2014): 151. http://dx.doi.org/10.1080/03632415.2014.893871.
Pełny tekst źródłaIvorra, Wilfrid. "Sur les équations xp+2βyp= z2et xp+2βyp= 2z2". Acta Arithmetica 108, № 4 (2003): 327–38. http://dx.doi.org/10.4064/aa108-4-3.
Pełny tekst źródłaLee, Jeeyun, Do Hoon Lim, Sung Kim, et al. "Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial." Journal of Clinical Oncology 30, no. 3 (2012): 268–73. http://dx.doi.org/10.1200/jco.2011.39.1953.
Pełny tekst źródłaFassihi, Hiva, Mieran Sethi, Heather Fawcett, et al. "Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect." Proceedings of the National Academy of Sciences 113, no. 9 (2016): E1236—E1245. http://dx.doi.org/10.1073/pnas.1519444113.
Pełny tekst źródłaAbid, Kalthoum, Jihene Bettaieb, Faouzi El Mezni, and Hamouda Boussen. "Proinflammatory cytokines in xeroderma pigmentosum (XP) and non-XP cancer patients—a pilot study." Exploration of Immunology 4, no. 4 (2024): 557–67. http://dx.doi.org/10.37349/ei.2024.00159.
Pełny tekst źródłaMaxmen, Amy. "XP mutant power!" Journal of Experimental Medicine 206, no. 13 (2009): 2856. http://dx.doi.org/10.1084/jem.20613iti2.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi та ін. "Общие аспекты пигментной ксеродермии: обзор". Núcleo do Conhecimento 11, № 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/ru/70626.
Pełny tekst źródłaKunwar, Sundar. "Enabling and Limiting factors in eXtreme Programming (XP) with Evaluation Framework." SCITECH Nepal 14, no. 1 (2019): 50–62. http://dx.doi.org/10.3126/scitech.v14i1.25534.
Pełny tekst źródłaRapićOtrin, Vesna, Isao Kuraoka, Tiziana Nardo, et al. "Relationship of the Xeroderma Pigmentosum Group E DNA Repair Defect to the Chromatin and DNA Binding Proteins UV-DDB and Replication Protein A." Molecular and Cellular Biology 18, no. 6 (1998): 3182–90. http://dx.doi.org/10.1128/mcb.18.6.3182.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Allgemeine Aspekte von Xeroderma pigmentosum: Eine Übersicht." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/gesundheit/aspekte-von-xeroderma.
Pełny tekst źródłaStanojevic, Jelena. "On estimation of high quantiles for certain classes of distributions." Yugoslav Journal of Operations Research 25, no. 2 (2015): 299–312. http://dx.doi.org/10.2298/yjor130606013s.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos gerais do xeroderma pigmentoso: Uma revisão." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/saude/aspectos-gerais-do-xeroderma.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspetti generali dello xeroderma pigmentoso: una revisione." Núcleo do Conhecimento 11, no. 03 (2022): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salute/generali-dello-xeroderma.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "General aspects of xeroderma pigmentosum: A review." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/xeroderma-pigmentosum.
Pełny tekst źródłaKim, Jinsu, and Wonho Lee. "Flood Inundation Analysis in Urban Area Using XP-SWMM." Journal of the Korean Geoenvironmental Society 16, no. 1 (2015): 29–36. http://dx.doi.org/10.14481/jkges.2015.16.1.29.
Pełny tekst źródłaSuman, AHM Khairul Imam, Khadija Begum, Kaniz Rahman, et al. "Association of Xanthelasma palpebrarum (XP) with cardiovascular disease (CVD) risk factors." Asian Journal of Medical and Biological Research 5, no. 4 (2020): 324–29. http://dx.doi.org/10.3329/ajmbr.v5i4.45271.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos generales del xeroderma pigmentoso: una revisión." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salud/xeroderma-pigmentoso.
Pełny tekst źródłaVaz-Garcia, Eduarda Santiago, Victor Talarico Leal Vieira, Natasha Pereira da Silva Ferreira Petitet, et al. "Mechanical Properties of Anatomic Finishing Files: XP-Endo Finisher and XP-Clean." Brazilian Dental Journal 29, no. 2 (2018): 208–13. http://dx.doi.org/10.1590/0103-6440201801903.
Pełny tekst źródłaGambichler, Thilo, Julia Hyun, Frank Oellig, Jürgen C. Becker, and Alexander Kreuter. "Immuncheckpoint‐Inhibitoren bei Kindern mit Xeroderma pigmentosum und fortgeschrittenem kutanen Plattenepithelkarzinom: Fallvorstellung und kurzer Überblick." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 23, no. 3 (2025): 303–10. https://doi.org/10.1111/ddg.15648_g.
Pełny tekst źródłaWebster, Mark A., Benjamin J. Brown, and Stephen D. Bartlett. "The XP Stabiliser Formalism: a Generalisation of the Pauli Stabiliser Formalism with Arbitrary Phases." Quantum 6 (September 22, 2022): 815. http://dx.doi.org/10.22331/q-2022-09-22-815.
Pełny tekst źródłaKim, Young Geun, Jae Wook Oh, Keun Cheol Lee, and Sung Ho Yoon. "Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum." Archives of Craniofacial Surgery 23, no. 2 (2022): 71–76. http://dx.doi.org/10.7181/acfs.2022.00185.
Pełny tekst źródłaPhillies, George David Joseph. "Simulational Tests of the Rouse Model." Polymers 15, no. 12 (2023): 2615. http://dx.doi.org/10.3390/polym15122615.
Pełny tekst źródłaPrice, Vera H. "Trichothiodystrophy: Current Concepts." Journal of Cutaneous Medicine and Surgery 1, no. 1 (1996): 45–49. http://dx.doi.org/10.1177/120347549600100113.
Pełny tekst źródłaMiao, Junjie, Changchun Chai, Wei Zhang, Yanxing Song, and Yintang Yang. "First-Principles Study on Structural, Mechanical, Anisotropic, Electronic and Thermal Properties of III-Phosphides: XP (X = Al, Ga, or In) in the P6422 Phase." Materials 13, no. 3 (2020): 686. http://dx.doi.org/10.3390/ma13030686.
Pełny tekst źródłaLee, J., W. Kang, D. Lim, et al. "Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis." Journal of Clinical Oncology 27, no. 15_suppl (2009): 4537. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4537.
Pełny tekst źródłaFernández-Sánchez, Javier. "Against a clausal ellipsis account of all stripping strings in Spanish." Poznan Studies in Contemporary Linguistics 55, no. 1 (2018): 53–87. http://dx.doi.org/10.1515/psicl-2019-0003.
Pełny tekst źródłaReifer, D. J. "XP and the CMM." IEEE Software 20, no. 3 (2003): 14–15. http://dx.doi.org/10.1109/ms.2003.1196314.
Pełny tekst źródłaTorre, Alberto C. de la. "The ubiquitous XP commutator." European Journal of Physics 27, no. 2 (2006): 225–30. http://dx.doi.org/10.1088/0143-0807/27/2/005.
Pełny tekst źródłaFraser, Steven, and Giancarlo Succi. "XP requirement negotiation workshop." ACM SIGAPP Applied Computing Review 10, no. 1 (2002): 26–31. http://dx.doi.org/10.1145/568235.568239.
Pełny tekst źródłaSchwarz, Diemo, and Etienne Brunet. "theconcatenator: Placard XP edit." Leonardo Music Journal 18 (December 2008): 89–90. http://dx.doi.org/10.1162/lmj.2008.18.89b.
Pełny tekst źródłaJ.-M.M. "XP Centaur en majesté." Revue Francophone des Laboratoires 2007, no. 388 (2007): 10. http://dx.doi.org/10.1016/s1773-035x(07)80003-7.
Pełny tekst źródłaGengler, Barbara. "XP a National Threat?" Network Security 2001, no. 11 (2001): 5. http://dx.doi.org/10.1016/s1353-4858(01)01111-4.
Pełny tekst źródłaSundar, Kunwar. "Extreme Programming (XP) Simplified." European Journal of Advances in Engineering and Technology 5, no. 3 (2018): 198–206. https://doi.org/10.5281/zenodo.10702437.
Pełny tekst źródłaBeroual, Nabil, and Ahmed Bendjeddou. "On a Predator–Prey System with Holling Functional Response: xp/(a + xp)." National Academy Science Letters 39, no. 1 (2015): 43–46. http://dx.doi.org/10.1007/s40009-015-0400-6.
Pełny tekst źródłaSarasin, Alain. "The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies." Cancers 15, no. 10 (2023): 2706. http://dx.doi.org/10.3390/cancers15102706.
Pełny tekst źródłaMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspects généraux de Xeroderma pigmentosum: un examen." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/sante/generaux-de-xeroderma.
Pełny tekst źródłaRana, MS, MM Rahman, UK Rima, and NS Juyena. "General anaesthesia of indigenous pigs in Bangladesh." Bangladesh Veterinarian 30, no. 2 (2014): 46–53. http://dx.doi.org/10.3329/bvet.v30i2.18254.
Pełny tekst źródłaKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428-3432.1986.
Pełny tekst źródłaKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428.
Pełny tekst źródłaMartens, M. C., L. Boeckmann, and S. Emmert. "Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom." Aktuelle Dermatologie 46, no. 08/09 (2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Pełny tekst źródłaHajar Tahiri, Fatima zahra El Fatoiki, Meriem Regragui, Fouzia. Hali, and Soumiya .Chiheb. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. http://dx.doi.org/10.30574/wjarr.2024.22.1.1179.
Pełny tekst źródłaHajar, Tahiri, zahra El Fatoiki Fatima, Regragui Meriem, Hali Fouzia., and .Chiheb Soumiya. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. https://doi.org/10.5281/zenodo.14225598.
Pełny tekst źródłaAlakshar, Asmaa, Abdul Rahman Mohammed Saleh, and Mehmet Omer Gorduysus. "Debris and Smear Layer Removal from Oval Root Canals Comparing XP-Endo Finisher, EndoActivator, and Manual Irrigation: A SEM Evaluation." European Journal of Dentistry 14, no. 04 (2020): 626–33. http://dx.doi.org/10.1055/s-0040-1714762.
Pełny tekst źródłaRothkopf, Michael. "An Algorithmic Approach for Lipid Metabolism and Management of Patients with Xanthelasma Palpebrarum (XP)." Current Developments in Nutrition 4, Supplement_2 (2020): 1140. http://dx.doi.org/10.1093/cdn/nzaa055_025.
Pełny tekst źródłaSugimoto, Naotoshi, Tetsuhiro Yoshinami, Sachiko Yamamoto, Toshinari Yagi, and Fumio Imamura. "Does capecitabine plus cisplatin (XP) give advanced or recurrent gastric cancer (AGC) patients higher early tumor shrinkage (ETS) rate than S1 plus cisplatin (SP) with safety?" Journal of Clinical Oncology 33, no. 3_suppl (2015): 172. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.172.
Pełny tekst źródłaTakeno, Atsushi, Youichi Makari, Shunji Endo, et al. "Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial." Journal of Clinical Oncology 36, no. 4_suppl (2018): 102. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.102.
Pełny tekst źródłaBahrudin, Ida Aryanie, Rafizah Mohd Hanifa, Mohd Ezree Abdullah, and Muhammad Firdaus Kamarudin. "Adapting eXtreme Programming Approach in Developing Electronic Document Online System (eDoc)." Applied Mechanics and Materials 321-324 (June 2013): 2938–41. http://dx.doi.org/10.4028/www.scientific.net/amm.321-324.2938.
Pełny tekst źródła